Infinity Pharmaceuticals, Inc. (INFI) Misses Q1 EPS by 3c

Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37). Revenue for the quarter came in at $25.2 million versus the consensus estimate of $26.18 million.

For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c
• Hitachi Ltd. (HIT) Misses Q2 EPS by 7c